BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3043391)

  • 1. [Lysosomal enzymes and their natural inhibitors in the serum and bronchoalveolar lavage fluid in chronic bronchitis and pneumonia].
    Płusa T; Zaraś E; Raczka A; Tchórzewski H; Kruszewski J; Frank-Piskorska A
    Pneumonol Pol; 1988 Mar; 56(3):94-9. PubMed ID: 3043391
    [No Abstract]   [Full Text] [Related]  

  • 2. Analysis of proteolytic enzymes and their natural inhibitors in serum and bronchial lavage fluid in atopic bronchial asthma, chronic bronchitis and pneumonia.
    Płusa T; Tchórzewski H
    Allerg Immunol (Leipz); 1985; 31(3):169-78. PubMed ID: 2416211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Proteolytic enzymes and their natural inhibitors in patients with bronchiectasis].
    Płusa T; Wasek Z; Zaraś E; Raczka A
    Wiad Lek; 1987 Nov; 40(22):1513-9. PubMed ID: 3330360
    [No Abstract]   [Full Text] [Related]  

  • 4. In vivo evaluation of bronchoalveolar lavage (BAL) fluid in atopic bronchial asthma, chronic bronchitis and sarcoidosis patients.
    Płusa T; Tchórzewski H
    Allerg Immunol (Leipz); 1990; 36(1):11-5. PubMed ID: 2189286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [General and local reactions in the proteolytic system during the development of experimental pneumonia].
    Kubyshkin AV
    Biull Eksp Biol Med; 1986 Oct; 102(10):400-2. PubMed ID: 3533173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of lysosomal enzymes and their natural inhibitors in bronchoalveolar lavage fluid and serum in atopic bronchial asthma.
    Plusa T; Tchórzewski H; Raczka A
    Arch Immunol Ther Exp (Warsz); 1987; 35(1):49-55. PubMed ID: 3307678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunobiochemical evaluation of bronchoalveolar lavage (BAL) in atopic bronchial asthma, chronic bronchitis and bronchiectasis.
    Plusa T; Wäsek Z
    Allergol Immunopathol (Madr); 1987; 15(4):209-13. PubMed ID: 3318350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The condition of pulmonary protective functions in patients with pneumonia accompanied by chronic viral hepatitis B].
    Velikaia OV; Provotorov VM
    Klin Med (Mosk); 2007; 85(10):34-7. PubMed ID: 18154177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Changes in the proteinase-inhibitor balance in bronchoalveolar lavage in experimental inflammation of the lung].
    Kubyshkin AV
    Probl Tuberk; 1988; (1):61-5. PubMed ID: 3283729
    [No Abstract]   [Full Text] [Related]  

  • 10. [Proteolysis enzymes and their inhibitors in acute diseases of the bronchopulmonary system in young children].
    Orliuk IB; Tebenchuk GM
    Pediatriia; 1982; (9):17-9. PubMed ID: 6755380
    [No Abstract]   [Full Text] [Related]  

  • 11. [Proteolytic enzymes and their inhibitors in acute experimental pneumonia].
    Kubyshkin AV
    Patol Fiziol Eksp Ter; 1987; (5):69-72. PubMed ID: 3324028
    [No Abstract]   [Full Text] [Related]  

  • 12. [Changes in protease inhibitor balance of the bronchoalveolar secretion in children with inflammatory lung diseases].
    Bogadel'nikov IV; Kubyshkin AV; Gavalova NG
    Pediatriia; 1990; (3):17-20. PubMed ID: 2385464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Proteolytic balance in patients with cancer of the lung].
    Płusa T; Zaraś E; Raczka A
    Nowotwory; 1989; 39(1):5-11. PubMed ID: 2682534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Proteolytic activity and trypsin inhibitor content in the blood serum in nonspecific lung diseases].
    Syromiatnikova NV; Goncharova VA; Zybina NN; Kutova AP
    Sov Med; 1978 Apr; (4):60-4. PubMed ID: 306685
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of proteinase inhibitors on efficiency of suppression of proteolytic activation in pneumonia].
    Kubyshkin AV; Fomochkina II
    Fiziol Zh (1994); 2009; 55(1):43-8. PubMed ID: 19441714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Activity of granulocyte proteases and their acid-resistant inhibitors in bronchial secretions of patients with tuberculosis, complicated by nonspecific endobronchitis].
    Shesterina MV; Ogloblina OG; Maliev BM
    Probl Tuberk; 1983 Feb; (2):51-5. PubMed ID: 6341984
    [No Abstract]   [Full Text] [Related]  

  • 17. [The state of the protease-inhibitor system in the bronchoalveolar lavage of patients with diffuse lung diseases].
    Kaminskaia GO; Stepanian IE; Zhukova NL
    Vopr Med Khim; 1988; 34(6):100-4. PubMed ID: 3070930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demonstration of C5 cleaving activity in bronchoalveolar fluids and cells: a mechanism of acute and chronic alveolitis.
    Desai U; Dickey B; Varani J; Kreutzer DL
    J Exp Pathol; 1984; 1(3):201-16. PubMed ID: 6400640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The correction of the imbalance in the proteinase-inhibitor system of patients with protracted pneumonia with the enterosorbent polifepan].
    Semenkova GG; Provotorov VM; Velikaia OV
    Klin Med (Mosk); 1995; 73(1):48-50. PubMed ID: 7791308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Protease activity and anti-protease activity in the saliva in chronic marginal periodontitis].
    Bukaresti L; Bocskay S; Nagy P; Fetzer AM; Sikó G
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Ser Stomatol; 1985; 32(3):179-84. PubMed ID: 2933778
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.